Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of Paroxysmal nocturnal hemoglobinuria by flow cytometry

Cytometry Part B - Clinical Cytometry

Volumn 76, Issue 1, 2009, Pages 47-55

  Richards, Stephen J ^a   Whitby, Liam ^b   Cullen, Matthew J ^a   Dickinson, Anita J ^a   Granger, Viv ^b   Reilly, John T ^b   Hillmen, Peter ^a   Barnett, David ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

CD55; CD59; Flow cytometry; GPI anchor; PNH; Quality control

Indexed keywords

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC TEST; ERYTHROCYTE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LIGHT SCATTERING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROCESS CONTROL; STANDARDIZATION;

ANTIGENS, CD; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; ERYTHROCYTES; FEASIBILITY STUDIES; FLOW CYTOMETRY; GPI-LINKED PROTEINS; GRANULOCYTES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LONGITUDINAL STUDIES; MASS SCREENING; PROTEIN STABILITY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 62349130455     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20438     Document Type: Article

References (25)

1. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-1258.
2. Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E. Paroxysmal nocturnal haemoglobinuria: Long term follow-up and prognostic factors. French society for haematology. Lancet 1996;348:573-577.
3. Hillmen P, Richards SJ. Implications of recent insights into the pathophysiology of PNH. Br J Haematol 2000;108:470-479.
4. Hill A, Richards SJ, Hillmen P. Recent developments in the understanding and management of PNH. Br J Haematol 2007;137:181-192.
5. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73:703-711.
6. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda N, Luzzatto L, Kinoshita T. Paroxysmal nocturnal hemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994; 13:110-117.
7. Borowitz MJ. Flow cytometry testing in PNH. How much is enough? Cytometry 2000;42:221-222.
8. Richards SJ, Rawstron AC, Hillmen P. The application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000;42:223-233.
9. van der Schoot CE, Huizinga TW, van't Veer-Korthof ET, Wijmans R, Pinkster J, von dem Borne AE. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990;76:1853-1859.
10. Schubert J, Alvarado M, Uciechowski P, Zielinska-Skowronek M, Freund M, Vogt H, Schmidt RE. Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 1991;79:487-492.
11. Barnett D, Granger V, Mayr P, Storie I, Wilson GA, Reilly JT. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring scheme. Cytometry Commun Clin Cytometry 1996;26:216-222.
12. + stem cell enumeration: Experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br J Haematol 1998;102:553-565.
13. + stem cell enumeration by the use of stable test material. Standard protocols and targeted training. Br J Haematol 2000;108:784-792.
14. + T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods 2001;257:145-154.
15. Barnett D, Granger V, Mayr P, Reilly JT. Preparation and stabilisation of leucocytes. UK 1998 Pat. No. 2,279,653. pp 1-40.
16. Richards SJ, Hillmen P.Immunophenotypic analysis of PNH cells. In: Robinson JP, editor. Current Protocols in Cytometry, Vol. 1. Hoboken, NJ: Wiley; 2002. pp 6.11.1-16.
17. Hall C, Richards SJ, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 2003;102:3587-3591.
18. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 2004:126;133-138.
19. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G;International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:3699-3709.
20. Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2000; 350:552-559.
21. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355:1233-1243.
22. Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, Mojcik CF, Rother RP. Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 2005;106: 2559-2565.
23. O'Gorman MRG, Scholl PR. Role of flow cytometry in the diagnostic evaluation of primary immunodeficiency disease. Clin Appl Immunol Rev 2002;2:321-355.
24. Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000;114:459-466.
25. Peghini PE, Fehr J. Clinical evaluation of an aerolysin-based screening test for paroxysmal nocturnal haemoglobinuria. Cytometry B 2005;67B:13-18.